- A Visual Guide to Heart Disease
- Medical Illustrations of the Heart Image Collection
- Take the Heart Disease Quiz!
What is Definity, and how does it work?
What are the side effects of Definity?
Common side effects of Definity include:
- injection site reactions,
- back and chest pain,
- hot flashes,
- fast or slow heart rate,
- high or low blood pressure,
- dry mouth,
- abdominal pain,
- joint pain,
- leg cramps,
- spinning sensation (vertigo),
- numbness and tingling,
- sore throat,
- runny or stuffy nose,
- shortness of breath,
- increased sweating, and
- dry skin.
SERIOUS CARDIOPULMONARY REACTIONS
Serious cardiopulmonary reactions, including fatalities, have occurred uncommonly during or following perflutren-containing microsphere administration. Most serious reactions occur within 30 minutes of administration.
- Assess all patients for the presence of any condition that precludes Definity administration.
- Always have resuscitation equipment and trained personnel readily available
What is the dosage for Definity?
Important Administration Instructions
- Definity is intended for administration only after activation in the Vialmix apparatus. Before injection, this product must be activated and prepared according to the instructions outlined below. The Vialmix apparatus should be ordered from Lantheus Medical Imaging, 331 Treble Cove Road, North Billerica, MA, 01862. For customer orders call 1-800-299-3431.
- Definity may be injected by either an intravenous (IV) bolus or infusion. Do not administer Definity by intra-arterial injection.
- The maximum dose is either two bolus doses or one single intravenous infusion. The safety of bolus and infusion dosing in combination or in sequence, has not been studied.
- The recommended bolus dose for activated Definity is 10 microliters (microL)/kg of the activated product by intravenous bolus injection within 30 to 60 seconds, followed by a 10 mL saline flush.
- If necessary, a second 10 microliters (microL)/kg dose followed by a second 10 mL saline flush may be administered 30 minutes after the first injection to prolong contrast enhancement.
- The recommended infusion dose for activated Definity is via an IV infusion of 1.3 mL added to 50 mL of preservative-free saline.
- The rate of infusion should be initiated at 4 mL/minute, but titrated as necessary to achieve optimal image enhancement, not to exceed 10 mL/minute.
- After baseline non-contrast echocardiography is completed, set the mechanical index for the ultrasound device at 0.8 or below.
- Then inject activated Definity (as described above) and begin ultrasound imaging immediately.
- Evaluate the activated Definity echocardiogram images in combination with the non-contrast echocardiogram images.
- In a crossover trial of 64 patients randomized to both bolus and infusion, the duration of clinically useful contrast enhancement for fundamental imaging was approximately 3.4 minutes after a 10 microL/kg bolus and was approximately 7.1 minutes during the continuous infusion of 1.3 mL activated Definity in 50 mL saline at a rate of 4 mL/min.
Definity Activation, Preparation And Handling Instructions
Follow directions for activation of Definity carefully and adhere to strict aseptic procedures during preparation.
Note: illustrations of this procedure are contained in the Vialmix or Vialmix RFID User's Guide.
Do not use this drug unless it has completed a full 45 second activation cycle in the Vialmix or Vialmix RFID. Definity will not be properly activated unless the full 45 second activation cycle is completed. Error messages will display if the vial is not properly activated. Do not reactivate the vial if Vialmix or Vialmix RFID did not properly activate the vial.
Never reactivate a successfully activated Definity vial (see step 3). A Vialmix or Vialmix RFID that is not functioning properly must never be used. Only use a vial activated from a properly functioning Vialmix or Vialmix RFID. Refer to the Vialmix or Vialmix RFID User's Guide to ensure that a properly functioning Vialmix or Vialmix RFID is used.
- Allow the vial to warm to room temperature before starting the activation procedure.
- Activate Definity by shaking the vial for 45 seconds using a Vialmix device or Vialmix RFID device.
- Immediately after activation in the Vialmix or Vialmix RFID, activated Definity appears as a milky white suspension and may be used immediately after activation. If the product is not used within 5 minutes of activation, the microspheres should be resuspended by 10 seconds of hand agitation by inverting the vial before the product is withdrawn in a syringe. The activated Definity may be used for up to 12 hours from the time of activation, but only after the microspheres are resuspended by hand agitation. Store the activated Definity at room temperature in the original product vial.
- 4. Invert the vial and withdraw the activated milky white suspension using the Intellipin (Dispensing Pin), the PINSYNC (Vented Vial Adapter 13mm), or 18 to 20 gauge syringe needle. Withdraw the material from the middle of the liquid in the inverted vial. Do not inject air into the Definity Vial.
- 5. Use the product immediately after its withdrawal from the vial; do not allow the product to stand in the syringe.
Special Instructions For The Definity Radio Frequency Identification (RFID)-Tagged Vial
This information is for vials containing Definity that have been labeled with a Radio Frequency Identification (RFID) tag. Full instructions for use of Vialmix RFID are provided on the Vialmix RFID screen and User's Guide.
- The RFID tag allows for the exchange of product information such as activation time and activation rate.
- Vialmix RFID will only activate Definity RFID-tagged vials. Function of the RFID technology is not dependent on vial orientation as it is placed in the Vialmix RFID. If the RFID tag is damaged or otherwise non-functional, the Vialmix RFID will notify the user and the vial with the nonfunctional RFID tag cannot be used to activate Definity with Vialmix RFID. Discard the nonfunctional RFID-tagged Definity vial.
- Follow all manufacturer's guidelines and do not operate any part of the Vialmix RFID and Definity RFID-tagged vials within 6 inches (15 cm) of a pacemaker and/or defibrillator.
Is Definity safe to use while pregnant or breastfeeding?
- Available data from case reports with Definity use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.
- Definity has a very short half-life; therefore, administration of Definity to a pregnant woman is not expected to result in clinically relevant fetal exposure.
- No adverse developmental outcomes were observed in animal reproduction studies with administration of activated Definity in pregnant rats and rabbits during organogenesis at doses up to 8 and 16 times, respectively, the maximum human dose based on body surface area. There are no data on the presence of
- Definity in human milk, the effects on the breastfed infant, or the effects on milk production.
- The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for Definity and any potential adverse effects on the breastfed infant from Definity or from the underlying maternal condition.
Latest Heart News
Daily Health News
Definity (perflutren lipid microsphere) Injectable Suspension is a contrast agent used to brighten and clarify images of the heart during echocardiograms.
Multimedia: Slideshows, Images & Quizzes
Heart Disease: Causes of a Heart Attack
Heart disease prevention includes controlling risk factors like diet, exercise, and stress. Heart disease symptoms in women may...
Am I Having a Heart Attack? Symptoms of Heart Disease
Heart attacks symptoms vary greatly for men and women, from anxiety and fatigue to nausea and sweating. Learn the warning signs...
Heart Disease: Symptoms, Signs, and Causes
What is heart disease (coronary artery disease)? Learn about the causes of heart disease, arrhythmias and myopathy. Symptoms of...
Heart Disease: Foods That Are Bad for Your Heart
If you want a healthy ticker, there are some foods you’ll want to indulge in every now and then only. Find out which ones and how...
Cardiac Arrest: What You Should Know
Cardiac arrest is a serious medical emergency that requires immediate medical care. Use this WebMD slideshow to know whether you...
Heart Disease Quiz: Test Your Medical IQ
Take our Heart Disease Quiz to get answers and facts about high cholesterol, atherosclerosis prevention, and the causes,...
Related Disease Conditions
Heart disease (coronary artery disease) occurs when plaque builds up in the coronary arteries, the vessels that supply blood to the heart. Heart disease can lead to heart attack. Risk factors for heart disease include: Smoking High blood pressure High cholesterol Diabetes Family history Obesity Angina, shortness of breath, and sweating are just a few symptoms that may indicate a heart attack. Treatment of heart disease involves control of heart disease risk factors through lifestyle changes, medications, and/or stenting or bypass surgery. Heart disease can be prevented by controlling heart disease risk factors.
Echocardiogram is a test using ultrasound to provide pictures of the heart's valves and chambers. There are several types of echocardiograms: transthoracic echocardiogram, transesophageal echocardiogram (TEE), stress echocardiogram, dobutamine or adenosine/sestamibi stress echocardiogram, and intravascular ultrasound.
Heart Disease: Sudden Cardiac Death
Second Source WebMD Medical Reference
Stress and Heart Disease
The connection between stress and heart disease is not clear. Stress itself may be a risk factor, or high levels of stress may make risk factors for heart disease worse. The warning signs of stress can be physical, mental, emotional, or behavioral. Reducing stressors in an individuals life not only can lead to a more productive life, but may also decrease the risk for heart disease and causes of heart disease.
Heart Disease in Women
Heart disease in women has somewhat different symptoms, risk factors, and treatment compared to heart disease in men. Many women and health professionals are not aware of the risk factors for heart disease in women and may delay diagnosis and treatment. Lifestyle factors such as diet, exercise, tobacco use, overweight/obesity, stress, alcohol consumption, and depression influence heart disease risk in women. High blood pressure, high cholesterol, and diabetes also increase women's risk of heart disease. Electrocardiogram (EKG or ECG), stress-ECG, endothelial testing, ankle-brachial index (ABI), echocardiogram, nuclear imaging, electron beam CT, and lab tests to assess blood lipids and biomarkers of inflammation are used to diagnose heart disease. Early diagnosis and treatment of heart disease in women saves lives. Heart disease can be prevented and reversed with lifestyle changes.
Congenital Heart Defects
Congenital heart defects are heart problems that are present at birth. Genetics may play a role in some heart defects. Symptoms can range from nonexistent to severe and life-threatening. Fatigue, rapid breathing, and decreased blood circulation are a few possible symptoms of congenital heart defects. Many cases do not require any treatment. Procedures using catheters and surgery may be used to repair severe heart defects.
Heart Disease Treatment in Women
Heart disease treatment in women should take into account female-specific guidelines that were developed by the American Heart Association. Risk factors and symptoms of heart disease in women differ from those in men. Treatment may include lifestyle modification (diet, exercise, weight management, smoking cessation, stress reduction), medications, percutaneous intervention procedure (PCI), and coronary artery bypass grafting (CABG). Heart disease is reversible with treatment.
Smoking and Heart Disease
Smoking increases the risk of heart disease in women and men. Nicotine in cigarettes decrease oxygen to the heart, increases blood pressure, blood clots, and damages coronary arteries. Learn how to quit smoking today, to prolong your life.
Treatment & Diagnosis
- Heart Disease FAQs
- Beta Carotene Supplements Not the Answer for Cancer or Heart Disease
- Heart Disease Risks Reduced With Running
- Heart Risks - Reduced By Walking & Vigorous Exercise
- Heart Disease In Women
- Ramipril, Heart Disease, Stroke & Diabetes
- Heart Disease & Stroke - Progress
- Heart Disease Stroke and Diabetes
- Exercise Therapy in Type 2 Diabetes - Part 1
- Heart Disease - Lessons Learned From Pitcher's Early Death
- Heart Disease: Antioxidant Supplements and Women
- Heart Disease Risk and C-reactive Protein (CRP)
- Hormone Therapy and and Heart Disease in Women
- What are The Complications of Rheumatic Heart Disease?
- Can I Still Get Heart Disease if I Take Blood Pressure Medication?
- Does Hashimoto's Affect Heart Disease and Osteoporosis?
- Heart Disease Prevention in Women
- Diabetes Update Day 4 - Heart Disease and Diabetes
- Heart Healthy Diet: Hypertension & Heart Disease
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.